Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study

By WebmasterSeptember 10, 2013November 1st, 2024No Comments

Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study
Read more here

Previous PostJenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037
Next PostGalderma Receives FDA Approval of Mirvaso®